ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.155,24
-0,04%
S&P 500
5.472,08
0,05%
Dow Jones
39.147,91
0,09%
Euro vs US Dollar
1,06861
-0,22%
Bitcoin
61.384,52
-0,69%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Cantabio Pharmaceuticals Inc (CE) (CTBO)

  7. Cantabio Pharmaceuticals Inc (CE) (CTBO) News

CTBO

Cantabio Pharmaceuticals (CE) (CTBO)

Cantabio Pharmaceuticals Inc (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:CTBO
DatumZeitQuelleÜberschriftSymbolFirma
21/06/201922h12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201922h09Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201922h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
17/06/201920h20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
24/05/201922h51Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
24/05/201922h36Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/05/201923h43Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/05/201923h39Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/05/201919h05Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/05/201918h55Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/04/201921h14Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
22/03/201919h25Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/03/201920h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/12/201820h27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
13/11/201818h56Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/10/201816h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201823h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201823h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201823h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
20/08/201821h55Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/08/201816h09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
16/07/201812h02Edgar (US Regulatory)Annual Report (10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
29/06/201816h54Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/06/201816h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/04/201816h33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
20/02/201818h42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/02/201821h17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
27/11/201718h41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/11/201720h56Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/08/201721h22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:CTBO

Kürzlich von Ihnen besucht

NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
DBI
DAX
DAX
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
USOTC
DTEGY
Deutsche Telekom (QX)
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten